Discharging Patients Is Safe, the Next Day After Minimalist TAVR

In a recent study published in the Journal of the American College of Cardiology (JACC), it was found that patients undergoing uncomplicated TAVR have a safe next-day discharge (NDD) profile with no difference in 30-day mortality rate in comparison to an increased length of hospital stay. In addition, the study also highlighted better 1-year clinical outcomes in patients as compared to non-NDD group. Continue reading

Recent Trends of TAVR in France

In a recent study published in the Journal of the American College of Cardiology, the implementation of Transcatheter Aortic Valve Replacement (TAVR) was investigated in France.

Continue reading

Delayed Coronary Obstruction: a post-TAVR Complication

A recently published study in the Journal of American College of Cardiology  concluded that delayed coronary obstruction (DCO) occurring after transcatheter aortic valve replacement (TAVR) is an infrequent complication, associated with a high in-hospital mortality. Continue reading

Assessment of Long-term Outcomes in Patients Undergoing SAVR

A contemporary cohort study recently published in Journal of the American College of Cardiology  highlighted the clinical significance of age and other associated comorbidities in determining the clinical outcome in patients undergoing surgical aortic valve replacement (SAVR). The 10-year mortality rate was found to be considerably high in elderly SAVR recipients of a bioprosthetic valve and almost one-third of the population exhibited subclinical structural valve degeneration (SVD). Continue reading

Frailty and Conventional Risk Scores in Patients Undergoing TAVR

The usage of combined risk models of frailty and conventional risk scores significantly enhances prediction of one-year mortality in patients undergoing TAVR, according to a recent publication in the Journal of American College of Cardiology.

Continue reading

SURTAVI Clinical Trial: TAVR vs surgical AVR Dr. Michael J. Reardon and Dr. Serge Korjian Discuss

Leaflet thrombosis in transcatheter and surgical bioprosthetic aortic valves Dr. Raj R. Makkar and Dr. C. Michael Gibson Discuss

Silent cerebral microbleeds during TAVR Dr. Eric Van Belle and Dr. Serge Korjian Discuss

Intersection of coronary artery disease and TAVR Dr. Duane Pinto, Dr. James Hermiller and Dr. C. Michael Gibson Discuss

State of the art in trans-septal therapies Dr. Zoltan Turi, Dr. George Hanzel and Dr. C. Michael Gibson Discuss

Pediatric VSD: What is it? Dr. Evan Zahn and Dr. C. Michael Gibson Discuss

State of the art in PFO Dr. John Carroll and Dr. C. Michael Gibson Discuss

Highlights from the CHD Track Dr. Henri Justino, Dr. Dennis Kim and Dr. C. Michael Gibson Discuss

Protection of the brain during open heart surgery by LAAO Dr. Helena Domínguez and Dr. Rim Halaby Discuss

Gender Differences in Outcomes With TAVR Women Undergoing TAVR are at a Decreased Risk of Long-term Mortality

In a recent meta-analysis published in the Journal of the American College of Cardiology, it was found that postoperative complications of Transcatheter Aortic Valve Replacement (TAVR) were different between males and females. While females were at increased risk of short-term complications (within 30 days) such as bleeding, stroke, and vascular complications, they had a lower incidence all-cause mortality within one year of the procedure. Continue reading

Protection of the brain during open heart surgery by surgical LAAO

Dr. Rim Halaby discusses the trial findings with Dr. Helena Domínguez at ESC 2017

State of the Art in Transseptal Therapies

Dr. Zoltan Turi, Dr. George Hanzel and Dr. C. Michael Gibson Discuss

Pediatric VSD: What Is It?

Dr. Evan Zahn and Dr. C. Michael Gibson Discuss

State of the Art in PFO

Dr. John Carroll and Dr. C. Michael Gibson Discuss